APSR2026-741

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-048
P125
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221191-46904-APSR2026ver3.0_433420.pdf
Format: PDF Only
16. Interstitial Lung Disease
15

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Koshi Saito * Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Yoshinori Tanino - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Natsumi Watanabe - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Takefumi Nikaido - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Yuki Sato - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Ryuichi Togawa - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Xintao Wang - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Ryutaro Tanaka - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Takahiro Kumanaka - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Tetsuya Egawa - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Hikaru Tomita - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Takashi Umeda - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Yasuhito Suzuki - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Kenya Kanazawa - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Yoko Shibata - Fukushima Medical University Department of Pulmonary Medicine Fukushima Japan
Presenting Author Details
Koshi
Saito
koshi@fmu.ac.jp
+818028404475
Under 30
Japan
Case Report
Secondary pulmonary alveolar proteinosis associated with GATA2 deficiency: A Case Report
Maximum 25 words
Abstract Content
 
 
 
 
Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of alveolar surfactant. Autoimmune PAP which is defined by the presence of anti-GM-CSF antibodies is the most frequent form which accounts for approximately 90% of all PAP. Secondary PAP (sPAP) is mainly due to hematological diseases, infection or dust exposure. GATA-binding protein 2 (GATA-2) is a transcriptional factor requiring for the differentiation and proliferation of hematopoietic stem cells, and GATA-2 deficiency is associated with several disorders such as recurrent non-tuberculous mycobacterial infections and hematological malignancies. Although GATA-2 deficiency can cause sPAP, the clinical characteristics of sPAP with GATA-2 deficiency has not clarified.
A 58-year-old man was referred to our hospital because of a refractory pneumonia. He has a history of multiple episodes of acute pneumonia. He was diagnosed with Pneumocystis jirovecii pneumonia, and corticosteroid and trimethoprim-sulfamethoxazole were given. However, his respiratory condition was gradually worsened after temporary improvement. BAL and TBLB were conducted, and he was diagnosed with PAP. Because serum anti GM-CSF antibody was not elevated, sPAP was suspected. He had complications of Mycobacterium avium pulmonary disease, multiple verruca vulgaris, and sensorineural hearing loss as well as loss of monocytes in peripheral blood. A genetic test identified heterozygous mutation of GATA-2 (c.1009C>T, p.Arg337Ter), leading to the diagnosis of sPAP with GATA-2 mutation. Because his respiratory condition got worsened, bilateral whole lung lavage was conducted. After the lavage, his respiratory condition was improved and stabilized without recurrent infections.
PAP is reported to be complicated in 18% of case of GATA-2 deficiency. However, the clinical characteristics of sPAP with GATA-2 deficiency is not clear. For example, whole lung lavage is reported to have poor response for sPAP. However, it was effective in the present case. Further studies including a large number of cases were necessary.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
secondary pulmonary alveolar proteinosis, GATA2 deficiency, case report
maximum 3 keywords and no abbreviations, separated by commas
None
299